Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 53, 5954-5961, December 15, 1993]
© 1993 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frisoli, J. K.
Right arrow Articles by Schomacker, K. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frisoli, J. K.
Right arrow Articles by Schomacker, K. T.

Pharmacokinetics of a Fluorescent Drug Using Laser-induced Fluorescence1

Joan K. Frisoli2, Eugene G. Tudor, Thomas J. Flotte, Tayyaba Hasan, Thomas F. Deutsch and Kevin T. Schomacker3

Wellman Laboratories of Photomedicine and the Departments of Dermatology, Massachusetts General Hospital [J. K. F., T. J. F., T. H., T. F. D., K. T. S.] and Otolaryngology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts 02114 [E. G. T.]

Laser-induced fluorescence has been used to measure tissue levels of chloroaluminum sulfonated phthalocyanine in vivo in an implanted hamster cheek pouch carcinoma tumor model. The drug was excited at 610 nm via a pulsed nitrogen laser-pumped dye laser, and fluorescence intensity was monitored at 684 nm for up to 30 days after drug administration. Data were acquired noninvasively with high temporal and spatial resolution using the laser-induced fluorescence apparatus and were analyzed with a multicompartment pharmacokinetic model. In addition, our published data on a C6-BAG glioma rat brain tumor model were analyzed to illustrate the effect of different tumor models on the rates. The rates extracted from the pharmacokinetic model elucidate the mechanisms of drug uptake and retention in the cheek pouch and brain tumor models. The laser-induced fluorescence approach should lead to better drug dosimetry for photochemotherapy and allow quick characterization of the pharmacokinetics of new photosensitizers in tissue.

1 This work was supported in part by the Medical Free Electron Laser Program of the Strategic Defense Initiative Organization, under Office of Naval Research Contract N00014-91-C-0084, and by NIH Grant HL46384.

2 Present address: Yale Medical School, 367 Cedar St., New Haven CT 06510.

3 To whom requests for reprints should be addressed.

Received 9/ 8/92. Accepted 10/ 6/93.




This article has been cited by other articles:


Home page
Cancer Res.Home page
S. Iinuma, K. T. Schomacker, G. Wagnieres, M. Rajadhyaksha, M. Bamberg, T. Momma, and T. Hasan
In Vivo Fluence Rate and Fractionation Effects on Tumor Response and Photobleaching: Photodynamic Therapy with Two Photosensitizers in an Orthotopic Rat Tumor Model
Cancer Res., December 1, 1999; 59(24): 6164 - 6170.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1993 by the American Association for Cancer Research.